How much did 207 pharmaceutical companies make in the first half of the year?

Source: according to the data statistics of Dongfang fortune.com, 207 pharmaceutical enterprises have published the 2016 mid level report as of August 31, 2016 Nine pharmaceutical enterprises have a revenue of over 10 billion yuan, and Shanghai Pharmaceutical ranks first From the perspective of business revenue, among the 207 pharmaceutical enterprises published in China Daily, there are nine top 10 billion enterprises, namely, Shanghai Pharmaceutical (59695.358 million yuan), Jiuzhoutong (29785.9185 million yuan), guoyaotong (14089.0529 million yuan), Nanjing Pharmaceutical (12960.4706 million yuan), Huadong Pharmaceutical (12243.6248 million yuan) RMB 10000), China Pharmaceutical (RMB 12029456100), Kangmei Pharmaceutical (RMB 11203498600), Baiyunshan (RMB 10857269300), Yunnan Baiyao (RMB 10452414500) Eight companies with a year-on-year growth rate of more than 100% were Tonghua Jinma (250.9%), Bohui innovation (237.75%), Jiuzhitang (208.02%), Zhongzhu medical (139.02%), Bikang (136.99%), Huayuan Biology (123.44%), Asia Pacific Pharmaceutical (114%) and Dean diagnostics (100.22%) In addition, revenue fell by 43 over the same period last year The net profit of five pharmaceutical enterprises exceeded 1 billion yuan, and the net profit of Yihua health increased by 82412.04% year on year From the perspective of net profit, there were 98 pharmaceutical enterprises with net profit of over 100 million yuan, among which, the top five enterprises were Kangmei Pharmaceutical (1766030800 yuan), Shanghai Pharmaceutical (1732458000 yuan), Fosun Pharmaceutical (1500266400 yuan), Yunnan Baiyao (138892200 yuan), Hengrui Pharmaceutical (Hengrui)（ 1314.322 million yuan), which is also five enterprises that have exceeded one billion yuan Among them, Yihua health has the most outstanding performance, with a year-on-year growth of 82412.04%, followed by guangyuyuan and Lukang medicine, with a year-on-year growth of 2689.35% and 2153.53% 57 companies including Sihuan Biology (- 219.95%) and Shuangcheng Pharmaceutical (- 188.71%) declined year on year In addition, among the 207 pharmaceutical enterprises, 7 have a loss in net profit, including Watson bio (- 161.9019 million yuan), Jiu'An medical (- 43.6601 million yuan), meinian health (- 22.4521 million yuan), Shuangcheng Pharmaceutical (- 1978.07 million yuan), Tianmu Pharmaceutical (- 8.2523 million yuan), Sihuan bio (- 4.9142 million yuan), Boji Pharmaceutical (- 1.6785 million yuan).